IPMK anticorps (AA 101-200) (Cy5)

N° du produit ABIN1704509

Détail du produit anti-IPMK anticorps (Cy5)

Antigène: IPMK (Inositol Polyphosphate Multikinase (IPMK))

Épitope: AA 101-200

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IPMK est conjugé à/à la Cy5

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Homologie: Human,Mouse,Rat,Cow,Sheep,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human IPMK

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur IPMK

Antigène: IPMK (Inositol Polyphosphate Multikinase (IPMK))

Autre désignation: IPMK (IPMK Produits)

Synonymes: anticorps 2410017C19Rik, anticorps AA408208, anticorps Impk, anticorps MGC83832, anticorps IPMK, anticorps zgc:158331, anticorps ipmk, anticorps si:dkey-223l5.1, anticorps Ipk2, anticorps ARABIDOPSIS THALIANA INOSITOL POLYPHOSPHATE KINASE 2 BETA, anticorps ATIPK2BETA, anticorps AtIpk2-beta, anticorps AtIpk2beta, anticorps INOSITOL POLYPHOSPHATE KINASE 2 BETA, anticorps IPK2B, anticorps MAC9.7, anticorps MAC9_7, anticorps inositol polyphosphate kinase 2 beta, anticorps inositol polyphosphate multikinase, anticorps inositol polyphosphate multikinase L homeolog, anticorps inositol polyphosphate multikinase b, anticorps inositol polyphosphate multikinase a, anticorps inositol polyphosphate kinase 2 beta, anticorps IPMK, anticorps Ipmk, anticorps ipmk.L, anticorps ipmkb, anticorps EDI_171250, anticorps CC1G_06147, anticorps CpipJ_CPIJ006477, anticorps CpipJ_CPIJ016779, anticorps PAAG_02384, anticorps MCYG_03683, anticorps ipmka, anticorps EDI_070480, anticorps VDBG_01275, anticorps MGYG_03269, anticorps Tsp_05937, anticorps IPK2BETA

Sujet:

Synonyms: 6-tetrakisphosphate 5-kinase, Inositol 1, Inositol 1,3,4,6 tetrakisphosphate 5 kinase, Inositol polyphosphate multikinase, Ipmk, IPMK_HUMAN

Background: Inositol polyphosphate multikinase (IPMK) belongs to the inositol phosphokinase (IPK) family and is characterized as having a broad substrate specificity. However, IPMK displays a preference for inositol-1,4,5-trisphosphate (Ins(1,4,5)P3) and inositol 1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4). IPMK is ubiquitously expressed with the highest expression in skeletal muscle, liver, placenta, lung, peripheral blood leukocytes, kidney, spleen and colon. IPMK is localized to the nucleus, where it may play a role in the regulation of calcium release from intracellular stores and has been implicated as a drug target for cancer therapies. The gene encoding IPMK maps to human chromosome 10, which contains over 800 genes. Notably, disorders linked to genes on chromosome 10 include Cowden syndrome, Cockayne syndrome and Tetrahydrobiopterin deficiency.

ID gène: 253430

Pathways: Tube Formation